Global Research Trends on the Treatment of Diffuse Large B-Cell Lymphoma: A Bibliometric and Visualized Study

被引:4
作者
Duan, Qintong [1 ]
Li, Yufeng [1 ]
Ou, Lijia [1 ]
Li, Yajun [2 ]
Zeng, Ruolan [2 ]
He, Yizi [2 ]
Pan, Tao [2 ]
Chen, Siwei [1 ]
Chen, Huan [3 ]
Zang, Hui [4 ]
Zhou, Hui [2 ]
Xiao, Ling [1 ]
机构
[1] Cent South Univ, Dept Histol & Embryol, Sch Basic Med Sci, Changsha, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Med Sch, Affiliated Tumor Hosp, Dept Lymphoma & Hematol, Changsha, Hunan, Peoples R China
[3] Hunan Univ Med, Sch Basic Med Sci, Dept Pathol & Pathophysiol, Huaihua 418000, Peoples R China
[4] Yiyang Med Coll, Dept Human Anat & Histoembryol, Sch Basic Med Sci, Yiyang, Peoples R China
来源
JOURNAL OF CANCER | 2022年 / 13卷 / 05期
基金
中国国家自然科学基金;
关键词
Key words; diffuse large B-cell Lymphoma (DLBCL); treatment; research progress; bibliometric analysis; Visualized; VOSviewer; PUBLIC-HEALTH RESEARCH; R-CHOP; PHASE-III; FRONTLINE RITUXIMAB; INFECTIOUS-DISEASES; SALVAGE REGIMENS; TRANSPLANTATION; LENALIDOMIDE; TRIAL; CYCLOPHOSPHAMIDE;
D O I
10.7150/jca.68453
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma subtype. Treatment of DLBCL has improved greatly in recent decades, with thousands of papers published. We conducted a bibliometric analysis of the literature on DLBCL treatment, and discussed cooperation among authors, countries, and institutions, and identified research hotspots for DLBCL treatment. We searched the Web of Science Core Collection (WOSCC) using "Diffuse Large B Cell Lymphoma or DLBCL" and "Treatment or Therapy or Clinical Trial" as the subject terms, and analyzed the publication year, research direction, country/region, institution, author, source publication, distribution of funding institutions, and other conditions provided by the database. In addition, scientometrics software was used to analyze literature citations and cooperative publications. Bibliometric analyses were performed using https://bibliometric.com/app and VOSviewer. Network maps were generated to evaluate collaborations between different authors, countries, institutions, and keywords. A total of 7,255 studies on treatment of DLBCL were retrieved from the WOSCC on February 19, 2021. We found that the number of publications increased gradually from 1999 to 2021, and this trend was relatively stable in the past 3 years. The countries that produced the most publications were the United States, China, and Japan. Among institutions, University of Texas MD Anderson Cancer Center published the most manuscripts. Furthermore, the United States also had the most annual publications, citations, distribution of journal sources, and funding. Cooperative research between countries is also relatively important to treatment of DLBCL. Therapeutic regimens such as CHOP and R-CHOP, and immunotherapy (CAR-T, PD1/PDL1, and CAR-NK, etc.), have received increased attention. Bibliometric analysis of studies related to DLBCL treatment can help researchers and clinical workers quickly understand the hotspots and development trends in this field, and provide reference for the formulation of public health policies.
引用
收藏
页码:1785 / 1795
页数:11
相关论文
共 50 条
  • [41] Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma Genetic Classification and Its Implications for Prognosis and Treatment
    Crombie, Jennifer L.
    Armand, Philippe
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2020, 29 (01) : 115 - +
  • [42] Emerging synthetic drugs for the treatment of diffuse large B-cell lymphoma
    Dong, Ning
    Perez-Lamas, Lucia
    Chavez, Julio C.
    EXPERT OPINION ON EMERGING DRUGS, 2023, 28 (03) : 181 - 190
  • [43] Intensive chemotherapy in the treatment of aggressive diffuse large B-cell lymphoma
    Agustin Avilés
    M. Jesús Nambo
    Natividad Neri
    Alejandra Talavera
    Claudia Castañeda
    Edgar Murillo
    Sergio Cleto
    Judith Huerta-Guzmán
    Medical Oncology, 2004, 21 : 269 - 272
  • [44] Global research trends in sexual health care: A bibliometric and visualized study
    Fu, Yao
    Zhao, Junbo
    Zhang, Wenjin
    Du, Hailiang
    Cao, Zhiqin
    Chen, Xingfeng
    JOURNAL OF CLINICAL NURSING, 2024, 33 (02) : 422 - 431
  • [45] Tafasitamab for the treatment of relapsed or refractory diffuse large B-cell lymphoma
    Salles, Gilles
    Dlugosz-Danecka, Monika
    Ghesquieres, Herve
    Jurczak, Wojciech
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (04) : 455 - 463
  • [46] Update on lymphoma management: Diffuse large B-cell NHL
    Vose, JM
    Neumann, M
    Harris, ME
    HEMATOLOGY, 2005, 10 : 10 - 14
  • [47] Global trends in research related to sleeve gastrectomy: A bibliometric and visualized study
    Barqawi, Abdulkarim
    Abushamma, Faris A. K.
    Akkawi, Maha
    Al-Jabi, Samah W.
    Shahwan, Moyad Jamal
    Jairoun, Ammar Abdulrahman
    Zyoud, Sa'ed H.
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2021, 13 (11): : 1509 - 1521
  • [48] Global research trends in perioperative care for the elderly: a bibliometric and visualized study
    Qinghua Chen
    Ya Wang
    Shengwen Song
    Guohao Xie
    Baoli Cheng
    Xiangming Fang
    Journal of Anesthesia, 2022, 36 : 210 - 220
  • [49] Global research trends in perioperative care for the elderly: a bibliometric and visualized study
    Chen, Qinghua
    Wang, Ya
    Song, Shengwen
    Xie, Guohao
    Cheng, Baoli
    Fang, Xiangming
    JOURNAL OF ANESTHESIA, 2022, 36 (02) : 210 - 220
  • [50] Current therapeutic strategies for diffuse large B-cell lymphoma
    Pfreundschuh, M.
    INTERNIST, 2016, 57 (03): : 214 - +